Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pettersson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Chemical Theory and Computation|November 18, 2015
SAXS-Guided MetadynamicsDari Kimanius, Ingrid Pettersson, Gerd Schluckebier, et al.
Biochemistry|April 2, 2008
Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor bindingTine Glendorf, Anders R Sørensen, Erica Nishimura, et al.
Plos One|June 2, 2017
IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718Mie Andersen, Dorte Nørgaard-Pedersen, Jakob Brandt, et al.
Biotechnology and Bioengineering|April 18, 2013
The challenge of improved secretory production of active pharmaceutical ingredients in Saccharomyces cerevisiae: a case study on human insulin analogsAli Kazemi Seresht, Eva A Palmqvist, Gerd Schluckebier, et al.
Journal of Computer-Aided Molecular Design|November 26, 2004
Docking and scoring of metallo-beta-lactamases inhibitorsLars Olsen, Ingrid Pettersson, Lars Hemmingsen, et al.
Bioorganic & Medicinal Chemistry|December 28, 2005
New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore designLars Olsen, Sandra Jost, Hans-Werner Adolph, et al.
Bioorganic & Medicinal Chemistry|April 28, 2004
Cinnamic amides of (S)-2-(aminomethyl)pyrrolidines are potent H3 antagonistsBernd Peschke, Sonja Bak, Rolf Hohlweg, et al.
Journal of Molecular Graphics & Modelling|November 9, 2004
The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptorPia Kahnberg, Michael H Howard, Tommy Liljefors, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
Journal of Medicinal Chemistry|April 14, 2006
4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modelingErik Lager, Pierre Andersson, Jakob Nilsson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Chemical Theory and Computation|November 18, 2015
SAXS-Guided MetadynamicsDari Kimanius, Ingrid Pettersson, Gerd Schluckebier, et al.
Biochemistry|April 2, 2008
Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor bindingTine Glendorf, Anders R Sørensen, Erica Nishimura, et al.
Plos One|June 2, 2017
IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718Mie Andersen, Dorte Nørgaard-Pedersen, Jakob Brandt, et al.
Biotechnology and Bioengineering|April 18, 2013
The challenge of improved secretory production of active pharmaceutical ingredients in Saccharomyces cerevisiae: a case study on human insulin analogsAli Kazemi Seresht, Eva A Palmqvist, Gerd Schluckebier, et al.
Journal of Computer-Aided Molecular Design|November 26, 2004
Docking and scoring of metallo-beta-lactamases inhibitorsLars Olsen, Ingrid Pettersson, Lars Hemmingsen, et al.
Bioorganic & Medicinal Chemistry|December 28, 2005
New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore designLars Olsen, Sandra Jost, Hans-Werner Adolph, et al.
Bioorganic & Medicinal Chemistry|April 28, 2004
Cinnamic amides of (S)-2-(aminomethyl)pyrrolidines are potent H3 antagonistsBernd Peschke, Sonja Bak, Rolf Hohlweg, et al.
Journal of Molecular Graphics & Modelling|November 9, 2004
The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptorPia Kahnberg, Michael H Howard, Tommy Liljefors, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
Journal of Medicinal Chemistry|April 14, 2006
4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modelingErik Lager, Pierre Andersson, Jakob Nilsson, et al.
Pageof 3